BC
LEGN icon

Bayforest Capital’s Legend Biotech LEGN Stock Holding History

Bayforest Capital’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$34.6K Sell
1,197
-2,331
-66% -$62.9K 0.03% 715
2026
Q1 		$63.8K Buy
+3,528
New +$67.3K 0.07% 501
2025
Q2 		– Sell
-1,227
Closed -$41.6K – 844
2025
Q1 		$41.6K Buy
1,227
+248
+25% +$8.89K 0.02% 580
2024
Q4 		$31.9K Buy
+979
New +$40.6K 0.04% 525

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Bayforest Capital's LEGN Position: Q2 2026 in Review

Bayforest Capital reduced its Legend Biotech (LEGN) stake by 66% in Q2 2026, selling an estimated $62.9K and leaving 1,197 shares worth $34.6K. The position accounts for 0.03% of the portfolio, ranked #715.

Bayforest Capital first reported a position in LEGN in Q4 2024 and has held it in 4 quarters since. The position peaked at $63.8K in Q1 2026. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Bayforest Capital held 1,197 shares of Legend Biotech worth $34.6K as of Q2 2026.
  • Bayforest Capital sold 2,331 Legend Biotech shares in Q2 2026, an estimated $62.9K.
  • Legend Biotech made up 0.03% of Bayforest Capital's portfolio in Q2 2026, its #715 holding.
  • Bayforest Capital first reported a position in Legend Biotech in Q4 2024 and has held it in 4 quarters since.
  • Bayforest Capital's Legend Biotech position peaked at $63.8K in Q1 2026.
  • 219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Bayforest Capital's 13F filing for Q2 2026, filed 5 Aug 2026.